SEC Form 4 · accession 0001209191-16-106571
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gordon Sutherland
Officer — SVP & GM, EMEA
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1,F2 | Mar 3, 2016 | A | 5,868 | $0.00 | A | 17,468 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F4,F3 | — | holding | — | — | — | — | — | Common Shares | 20,000 | 20,000 | D |
Explanation of responses
- F1Restricted stock units granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in 1/3 annual increments over three years commencing on May 15, 2017.
- F2The total number of common shares represents restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan.
- F3No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- F4The reporting person holds previously reported options to buy 20,000 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 14, 2012 and March 18, 2013, at exercise prices between $13.37 to $14.49 per share, will expire between August 14, 2022 and March 18, 2023, and became or will become exercisable between September 20, 2013 and March 31, 2017.